<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-54</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-7-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cerebrovascular Disease</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>CVA with Neurofibromatosis Type I</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>07</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>7</issue>
<fpage>54</fpage>
<lpage>55</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1177/000992289203100511" vol="31" page="313">
<article-title>Progressive occlusive cerebrovascular disease in a patient with neurofibromatosis type 1</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>A two year old developmentally delayed girl with neurofibromatosis type I and a sudden onset of left sided hemiparesis is reported from the Children&#x2019;s National Medical Center and George Washington University School of Medicine, Washington, D.C.</p>
</abstract>
<kwd-group>
<kwd>Neurofibromatosis Type I</kwd>
<kwd>Cerebral Angiography</kwd>
<kwd>Moyamoya</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>A two year old developmentally delayed girl with neurofibromatosis type I and a sudden onset of left sided hemiparesis is reported from the Children&#x2019;s National Medical Center and George Washington University School of Medicine, Washington, D.C. There was no history of sickle cell disease or hypertension. The hemiparesis gradually improved and the patient received aspirin, 80 mg. daily. Four months later there was a left focal seizure and an acute progression of the left hemiparesis. At 5 years of age the patient presented with sudden right-sided weakness and right focal seizure. Cerebral angiography revealed bilateral distal internal carotid arterial occlusion. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> Moyamoya may be seen in association with a number of systemic conditions including NF-1 or as a distinct disease entity of unclear etiology. Occlusion of the intracranial arteries is a rare complication of NF-1 and the progressive occlusion noted in this case appears to be unique.</p>
<p>The gene for NF-1 has been mapped to chromosome 17 and closely linked DNA markers have made accurate diagnosis by linkage analysis possible in most cases of familial NF-1. DNA testing by linkage analysis on 24 individuals with a family history of NF-1 and on 9 couples who requested testing for prenatal diagnosis was found useful as an adjunct to the clinical diagnosis 1) in children less than 6 years of age with incomplete clinical signs, 2) in NF-1 families for prenatal testing, and 3) when complete clinical examination is impracticle. [<xref ref-type="bibr" rid="CIT0002">2</xref>]</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorelick</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Rosenbaum</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Saal</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Conry</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fitz</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Progressive occlusive cerebrovascular disease in a patient with neurofibromatosis type 1</article-title>
<source>Clin Pediatr</source>
<year>1992</year>
<month>May</month>
<volume>31</volume>
<issue>5</issue>
<fpage>313</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1177/000992289203100511</pub-id>
<pub-id pub-id-type="pmid">1582101</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofman</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Familial neurofibromatosis type 1: clinical experience with DNA testing</article-title>
<source>J Pediatr</source>
<year>1992</year>
<month>Mar</month>
<volume>120</volume>
<issue>3</issue>
<fpage>394</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(05)80903-5</pub-id>
<pub-id pub-id-type="pmid">1347082</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>